agilon health's (AGL) Outperform Rating Reaffirmed at Royal Bank of Canada

agilon health (NYSE:AGL - Get Free Report)'s stock had its "outperform" rating reiterated by stock analysts at Royal Bank of Canada in a note issued to investors on Tuesday,Benzinga reports. They presently have a $3.00 price objective on the stock. Royal Bank of Canada's target price would indicate a potential upside of 88.68% from the stock's previous close.

A number of other analysts also recently weighed in on the company. Citigroup decreased their price target on agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft decreased their price target on agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a report on Friday, August 9th. TD Cowen decreased their price target on agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a report on Monday, November 11th. Barclays decreased their price target on agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a report on Monday, November 11th. Finally, JMP Securities downgraded agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, agilon health currently has an average rating of "Hold" and a consensus target price of $6.05.

agilon health Trading Up 1.3 %

NYSE AGL traded up $0.02 on Tuesday, reaching $1.59. The company had a trading volume of 3,553,884 shares, compared to its average volume of 4,957,898. The firm has a market cap of $655.11 million, a price-to-earnings ratio of -1.69 and a beta of 0.60. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $13.76. The business has a 50 day moving average of $2.97 and a two-hundred day moving average of $4.81. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the company earned ($0.06) earnings per share. Analysts forecast that agilon health will post -0.47 EPS for the current year.

Insider Activity

In related news, CEO Steven Sell purchased 20,000 shares of the firm's stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock worth $176,582,000 after buying an additional 371,537 shares in the last quarter. AQR Capital Management LLC raised its stake in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock worth $8,871,000 after buying an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its stake in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after buying an additional 316,856 shares in the last quarter. Capital International Investors raised its stake in agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company's stock worth $123,207,000 after buying an additional 9,263,296 shares in the last quarter. Finally, Simplicity Wealth LLC raised its stake in agilon health by 145.1% in the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company's stock worth $171,000 after buying an additional 15,515 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.